Search Tag: multiple sclerosis
2024 08 Sep
Accurately diagnosing and predicting disease progression in Multiple Sclerosis (MS) are critical to providing timely and effective treatment. Key to this process are MRI and biofluid biomarkers, which offer invaluable insights into disease activity, progression, and response to immunotherapy. Recent studies have focused on the evolving role...Read more
2024 08 Sep
Accurately diagnosing and predicting disease progression in Multiple Sclerosis (MS) are critical to providing timely and effective treatment. Key to this process are MRI and biofluid biomarkers, which offer invaluable insights into disease activity, progression, and response to immunotherapy. Recent studies have focused on the evolving role...Read more
2020 21 Sep
Siemens Healthineers and Novartis collaboration to develop assays supporting Novartis’s therapeutic pipeline. Initial program to focus on development of serum neurofilament light chain (sNFL) immunoassay for people living with Multiple Sclerosis (MS) and other neurological diseases. Global distribution on Siemens Healthineers immunoassay platforms....Read more
2020 21 Sep
Siemens Healthineers and Novartis collaboration to develop assays supporting Novartis’s therapeutic pipeline. Initial program to focus on development of serum neurofilament light chain (sNFL) immunoassay for people living with Multiple Sclerosis (MS) and other neurological diseases. Global distribution on Siemens Healthineers immunoassay platforms....Read more
2020 04 Sep
In the UK, a multicentre randomised clinical trial was conducted between April 2015 and November 2017 to evaluate the effectiveness of short-term integrated palliative care for people with long-term neurological conditions (LTNCs). You might also like: A Systems Perspective on Collaborative Care Delivery Based on the results,...Read more
2019 22 May
Affidea applies ground-breaking AI technology on Brain MRI examinations for people with Multiple Sclerosis Affidea has entered into a partnership with icometrix, a data science company that develops Artificial Intelligence (AI) solutions for healthcare, to standardise and improve the care of patients with neurological disorders. The official...Read more
2019 22 May
How can healthcare accelerate the implementation of the science? Where is Personalised Medicine (PM) already improving the lives of patients and what is needed to make it the standard of care across multiple conditions? What’s your brief at the PMC? I have a science and genetics background and bring scientific...Read more
2019 17 Apr
MRI elastography: ground-breaking new way to see extremely fast neuronal activity in the brain It is magnificent how fast the human brain operates. In a fraction of a second our neurons are activated, creating thoughts and reactions to stimuli. The speed at which radiologists can non-invasively follow brain function using MRI , however, is...Read more
2019 01 Mar
Affidea and icometrix have today announced a strategic partnership to streamline and improve the care of patients with neurological disorders in Europe, with the rollout of a new AI tool for patients with multiple sclerosis (MS). As the leading European provider of advanced diagnostic imaging services, Affidea is starting the collaboration...Read more
2019 06 Feb
Which is the horse and which is the jockey? Let us share some interesting study findings and aspects on the relation of autonomic function and neurological disorders: Neurological diseases are very often associated with autonomic dysfunction – or the other way round? Migraine, Multiple Sclerosis or Parkinson’s Disease are only a few...Read more
2018 25 Jul
Researchers have tested a new MRI technique, called quantitative susceptibility mapping (QSM), to track iron levels in the brains of multiple sclerosis patients. They found that brain iron levels can help identify those at a higher risk for developing physical disability, according to a new study published in the journal Radiology. Multiple...Read more
2017 17 Jan
Project will explore quantitative MRI metrics for more informed treatment decision making Siemens Healthineers and Biogen has announced that the companies plan to jointly develop magnetic resonance imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Biogen...Read more
2014 08 Nov
As the newly installed President of the European Society of Neuroradiology (ESNR), what are your goals for your term of office? The ESNR is a professional society with more than 3,000 members. A strategic plan and mission for the ESNR was initiated a few years ago. Under my presidency we will expand, improve and update this concept. The ESNR will continue...Read more
2014 25 Sep
A new drug candidate, RPC1063, has shown promising results for relapsing multiple sclerosis. The drug was first discovered at The Scripps Research Institute (TSRI) and then synthesised and further developed in the laboratories of Scripps California by Professor Ed Roberts and Professor Hugh Rosen. Rosen was a key scientist behind the discovery and...Read more
2014 26 Aug
According to new research published online in the journal Radiology, the Nintendo Wii Balance Board system can help people with multiple sclerosis (MS) reduce their risk of accidental falls. MRI scans reveal that the balance board system induces favourable changes in brain connections associated with balance and movement. MS is a disease of the central...Read more